Skip to Content

MainStay Candriam Emerging Mkts Dbt I MGHIX Fund Analysis

| Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis MGHIX

Will MGHIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Candriam Emerging Mkts Dbt I earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor